Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages

Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBDs) which burden health systems worldwide; available pharmacological therapies are limited and cost-intensive. Use of peroxisome proliferator activated-receptor γ (PPARγ) ligands for IBD treatment, while promising, lac...

Descripción completa

Detalles Bibliográficos
Autores principales: da Rocha, Gustavo Henrique Oliveira, de Paula-Silva, Marina, Broering, Milena Fronza, Scharf, Pablo Rhasan dos Santos, Matsuyama, Larissa Satiko Alcântara Sekimoto, Maria-Engler, Silvya Stuchi, Farsky, Sandra Helena Poliselli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845455/
https://www.ncbi.nlm.nih.gov/pubmed/33519451
http://dx.doi.org/10.3389/fphar.2020.591561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845455/
https://www.ncbi.nlm.nih.gov/pubmed/33519451
http://dx.doi.org/10.3389/fphar.2020.591561

Ejemplares similares